- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Cara Therapeutics (NASDAQ:CARA), Quotes and News Summary
Cara Therapeutics (NASDAQ: CARA)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-07 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.250 | -0.080 | 0.1700 | ||||
| REV | 20.710M | 23.003M | 2.293M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Cara Therapeutics Questions & Answers
You can purchase shares of Cara Therapeutics (NASDAQ: CARA) through any online brokerage.
Other companies in Cara Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and DICE Therapeutics (NASDAQ:DICE).
The latest price target for Cara Therapeutics (NASDAQ: CARA) was reported by Canaccord Genuity on Monday, March 14, 2022. The analyst firm set a price target for 29.00 expecting CARA to rise to within 12 months (a possible 157.78% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Cara Therapeutics (NASDAQ: CARA) is $11.25 last updated August 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Cara Therapeutics.
Cara Therapeutics’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Cara Therapeutics.
Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.